A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma

Clinical trial NCT06670105 · WITHDRAWN

Trial details

NCT number: NCT06670105
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Lymphoma

Start date: 2025-06-06
Primary completion: 2030-01-06
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.